Dachaigh › Aillse Sgamhain Neo-chealla-beag › Pennsylvania › Reading
Sgrùdaidhean clionaigeach Aillse Sgamhain Neo-chealla-beag ann an Reading, PA
Tha 9 sgrùdaidhean airson Aillse Sgamhain Neo-chealla-beag a’ lorg phàirtichean aig làraichean ann agus timcheall air Reading (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
A’ fastadhÌre 3
- Reading Hospital, West Reading · 1 mìle air falbh
- Ephrata Cancer Center, Ephrata · 17 mìle air falbh
- Sechler Family Cancer Center, Lebanon · 26 mìle air falbh
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
A’ fastadhÌre 3
- Reading Hospital, West Reading · 1 mìle air falbh
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A’ fastadhÌre 2
- McGlinn Cancer Institute Reading Hospital, West Reading · 1 mìle air falbh
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A’ fastadhÌre 3
- Reading Hospital - McGlinn Cancer Institute, West Reading · 1 mìle air falbh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- Ephrata Cancer Center, Ephrata · 17 mìle air falbh
- Sechler Family Cancer Center, Lebanon · 26 mìle air falbh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- Ephrata Cancer Center, Ephrata · 17 mìle air falbh
- Sechler Family Cancer Center, Lebanon · 26 mìle air falbh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2/3
- Ephrata Cancer Center, Ephrata · 17 mìle air falbh
- Sechler Family Cancer Center, Lebanon · 26 mìle air falbh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- Ephrata Cancer Center, Ephrata · 17 mìle air falbh
- Sechler Family Cancer Center, Lebanon · 26 mìle air falbh
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A’ fastadhSgrùdadh amharc
- Ephrata Cancer Center, Ephrata · 17 mìle air falbh
- Sechler Family Cancer Center, Lebanon · 26 mìle air falbh
Sgrùdaidhean Aillse Sgamhain Neo-chealla-beag ann am bailtean eile
- Houston, TX145 sgrùdaidhean
- New York City, NY121 sgrùdaidhean
- Arlington, VA104 sgrùdaidhean
- Nashville, TN97 sgrùdaidhean
- Boston, MA90 sgrùdaidhean
- Los Angeles, CA87 sgrùdaidhean
- St. Louis, MO73 sgrùdaidhean
- Chicago, IL61 sgrùdaidhean
- Baltimore, MD60 sgrùdaidhean
- San Antonio, TX59 sgrùdaidhean
- Columbus, OH57 sgrùdaidhean
- Washington, DC55 sgrùdaidhean
Sgrùdaidhean eile ann an Reading
- Ailseachadh nan Sgamhan11 sgrùdadh
- Aillse a' bhroilleach5 sgrùdaidhean
- Leukemia myeloid geur5 sgrùdaidhean
- Galaran Somnolence Ro-mhòr5 sgrùdaidhean
- Aillse (gach seòrsa)4 sgrùdaidhean
- Aillse Prostata4 sgrùdaidhean
- Narcolepsy3 sgrùdaidhean
- Mì-rianan cadail3 sgrùdaidhean
- Sgìths3 sgrùdaidhean
- Aillse colorectal3 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.